NO20032217L - Type III-sekresjonsrute i Aeromonas salmonicida og anvendelse derav - Google Patents

Type III-sekresjonsrute i Aeromonas salmonicida og anvendelse derav

Info

Publication number
NO20032217L
NO20032217L NO20032217A NO20032217A NO20032217L NO 20032217 L NO20032217 L NO 20032217L NO 20032217 A NO20032217 A NO 20032217A NO 20032217 A NO20032217 A NO 20032217A NO 20032217 L NO20032217 L NO 20032217L
Authority
NO
Norway
Prior art keywords
type iii
iii secretion
aeromonas salmonicida
secretion route
route
Prior art date
Application number
NO20032217A
Other languages
English (en)
Other versions
NO20032217D0 (no
NO335842B1 (no
Inventor
Joachim Frey
Julian C Thornton
Michael A Kuzik
Jan Burian
Katja Stuber
Original Assignee
Univ Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bern filed Critical Univ Bern
Publication of NO20032217D0 publication Critical patent/NO20032217D0/no
Publication of NO20032217L publication Critical patent/NO20032217L/no
Publication of NO335842B1 publication Critical patent/NO335842B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
NO20032217A 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse. NO335842B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24886400P 2000-11-15 2000-11-15
PCT/CA2001/001589 WO2002040514A2 (en) 2000-11-15 2001-11-15 Type iii secretion pathway in aeromonas salmonicida, and uses therefor

Publications (3)

Publication Number Publication Date
NO20032217D0 NO20032217D0 (no) 2003-05-15
NO20032217L true NO20032217L (no) 2003-07-09
NO335842B1 NO335842B1 (no) 2015-03-02

Family

ID=22941002

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20032217A NO335842B1 (no) 2000-11-15 2003-05-15 Aeromonas calcium respons D polypetid og isolert nukleinsyrefragment samt anvendelse av disse.
NO20032218A NO335752B1 (no) 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet.
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20032218A NO335752B1 (no) 2000-11-15 2003-05-15 Eksoenzymtoksin og nukleinsyrefragment fra Aeromonas salmonicida, vaksine og anvendelse derav samt fremgangsmåte for indusering av toksinet.
NO20141517A NO20141517L (no) 2000-11-15 2014-12-17 Ny type III-sekresjonsvei i Aeromonas salmonicida og anvendelse derav

Country Status (6)

Country Link
US (6) US7351550B2 (no)
AU (2) AU2002214891A1 (no)
CA (4) CA2749307C (no)
GB (2) GB2385854A (no)
NO (3) NO335842B1 (no)
WO (2) WO2002040515A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007339423B2 (en) * 2006-08-14 2012-11-15 Biocontrol Systems, Inc. Method for detecting pathogens
WO2009145829A1 (en) * 2008-04-01 2009-12-03 University Of Massachusetts Type iii secretion inhibitors, analogs and uses thereof
US20100322957A1 (en) * 2009-05-22 2010-12-23 Aderem Alan A Secretion-related bacterial proteins for nlrc4 stimulation
CN108251341B (zh) * 2018-03-27 2020-11-06 北京鼎持生物技术有限公司 一种铜绿假单胞菌以及含该菌的海洋哺乳动物疫苗
CN110922454B (zh) * 2019-12-05 2020-11-06 中国科学院深圳先进技术研究院 绿脓杆菌毒素ExoS和ExoT的免疫用途及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
GB2308367B (en) * 1995-12-22 1999-10-13 Scottish Salmon Growers Ass Aeromonas protein used as a vaccine component

Also Published As

Publication number Publication date
AU2002223328A1 (en) 2002-05-27
US20100008895A1 (en) 2010-01-14
NO20032218L (no) 2003-07-14
WO2002040515A3 (en) 2002-12-27
CA2467360A1 (en) 2002-05-23
US7579011B2 (en) 2009-08-25
NO20032218D0 (no) 2003-05-15
US7351550B2 (en) 2008-04-01
US20050058662A1 (en) 2005-03-17
US20090226462A1 (en) 2009-09-10
NO20032217D0 (no) 2003-05-15
WO2002040514A3 (en) 2002-12-27
NO20141517L (no) 2003-07-09
AU2002214891A1 (en) 2002-05-27
US20070269462A1 (en) 2007-11-22
US7232569B2 (en) 2007-06-19
NO335752B1 (no) 2015-02-02
US7815896B2 (en) 2010-10-19
WO2002040514A2 (en) 2002-05-23
US20050158344A1 (en) 2005-07-21
NO335842B1 (no) 2015-03-02
GB2389112A (en) 2003-12-03
US7851197B2 (en) 2010-12-14
CA2749307A1 (en) 2002-05-23
US7538208B2 (en) 2009-05-26
CA2467309A1 (en) 2002-05-23
GB0313840D0 (en) 2003-07-23
WO2002040515A2 (en) 2002-05-23
CA2707684C (en) 2013-12-24
GB0313912D0 (en) 2003-07-23
GB2385854A (en) 2003-09-03
CA2467360C (en) 2016-08-16
US20090074817A1 (en) 2009-03-19
CA2467309C (en) 2014-08-26
CA2707684A1 (en) 2002-05-23
CA2749307C (en) 2015-03-17

Similar Documents

Publication Publication Date Title
IS6885A (is) Burðarefni ásamt fíbrínógeni og þrombíni á föstu formi
NO20020343L (no) Kaspase-inhibitorer og anvendelse derav
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20025018L (no) Selektiv hydroprosessering og merkaptanfjerning
DK1282611T3 (da) Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
DK1305301T3 (da) Alpha-acyl- og alpha-heteroatomsubstituerede benzenacetamidglucokinase-aktivatorer
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
CY2008006I1 (el) Παραγωγα τροπανιου χρησιμα στη θepαπευτικη
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
IS6411A (is) Kaspasa tálmar og notkun þeirra
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
AR028035A1 (es) Barras y procedimiento para realizar dichas barras
NO20031848L (no) Polyuretan elastomer gel isolerende sammensetning og anvendelse derav
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20025158L (no) Lipidpreparat og anvendelse derav
DK1254240T3 (da) Hybrid protease med reduceret antigenicitet og dens anvendelse
NO20030882D0 (no) Glasskeramikkmasse og anvendelse derav
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
NO20032217L (no) Type III-sekresjonsrute i Aeromonas salmonicida og anvendelse derav
NO20023442L (no) N¶ringsmiddel og fremgangsmåte
NO20030156L (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE60140717D1 (de) Dekodierungsschaltkreis und zugehöriges Dekodierungsverfahren
NO20014946D0 (no) Strukturerte flerbrukspakninger og deres anvendelse
NO20032010D0 (no) Ikke-aspirerende overgangsviskosielastikker for anvendelse i kirurgi
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS POSTBOKS 2003 VIKA OSLO, 0125 NO

MK1K Patent expired